Thank you to the more than 200 attendees of the 2017 Technology Showcase. The event provided a great opportunity to learn about...

Researchers at the NCI conducted the first in-human trials of avelumab, an immunotherapy drug that targets the protein programmed...

The NCI Technology Transfer Center (TTC) has fellowship opportunities available to qualified candidates in the fast growing field...

George N. Pavlakis, M.D., Ph.D., head of NCI’s Vaccine Branch and John T. Schiller, Ph.D., deputy chief of NCI’s...